Bioorganic and Medicinal Chemistry Letters p. 1231 - 1236 (1998)
Update date:2022-08-03
Topics:
Gleave, D. Mark
Brickner, Steven J.
Manninen, Peter R.
Allwine, Debra A.
Lovasz, Kristine D.
Rohrer, Douglas C.
Tucker, John A.
Zurenko, Gary E.
Ford, Charles W.
A series of conformationally restricted, [6,5,5] and [6,6,5] tricyclic fused oxazolidinones were synthesized and tested for antibacterial activity. Several compounds in the trans-[6,5,5] series demonstrated potent in vitro and in vivo activity. This work provides valuable information regarding the preferred conformational orientation of the oxazolidinones at the binding site.
View MoreShantou Baokang Pharmaceutical Co., Ltd.
Contact:+86-754-88873487
Address:5/F B Block Huangshan Bldg Huangshan Rd Shantou
Contact:
Address:308# dongwu avenue dongxihu district wuhan city
website:https://www.finerchem.com
Contact:+86-531-88989536
Address:New Material Industrial Park, Jinan City, China
Dalian Join King Biochemical Tech. Co., Ltd.
Contact:0411 39216206
Address:814 First State Blvd
Improve Medical Technology(Nanxiong) Co., Ltd
Contact:86-751-3836997
Address:No.33, Pingan First Road, Fine Chemical Industry Base, Nanxiong City, Shaoguan, Guangdong, China
Doi:10.1016/S0040-4039(02)00857-2
(2002)Doi:10.1021/om980035w
(1998)Doi:10.1016/j.bmcl.2004.02.071
(2004)Doi:10.1021/acs.orglett.5b00295
(2015)Doi:10.1016/S0022-328X(97)00720-1
(1998)Doi:10.1021/jo980367a
(1998)
